Holen Sie sich die Stockscreener-App
34.00
3.76%
-1.33
Handel nachbörslich:
34.00
Finanzdaten der Cogent Biosciences Inc-Aktie (COGT)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
| Research and Development |
9.52%
75.56
|
68.99 | 62.20 | 63.03 | 62.05 |
| Costs And Expenses |
19.36%
99.49
|
83.36 | 75.58 | 74.93 | 73.73 |
| Depreciation and Amortization |
3.59%
0.664
|
0.641 | 0.655 | 0.64 | 0.675 |
| Operating Income/Loss |
19.36%
-99.49
|
-83.36 | -75.58 | -74.93 | -73.73 |
| Nonoperating Income/Loss |
223.67%
-2.999
|
2.425 | 2.053 | 2.947 | 5.807 |
| Income/Loss From Continuing Operations Before Tax |
22.96%
-102.49
|
-83.36 | -73.53 | -71.99 | -67.93 |
| Income/Loss From Continuing Operations After Tax |
26.64%
-102.49
|
-80.93 | -73.53 | -71.99 | -67.93 |
Net Income/Loss
|
26.64%
-102.49
|
-80.93 | -73.53 | -71.99 | -67.93 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
94.88%
7.0359
|
137.55 | 114.47 | 113.31 | 2.4212 |
| Diluted Average Shares |
94.88%
7.0359
|
137.55 | 114.47 | 113.31 | 2.4212 |
| Basic Earnings Per Share |
22.00%
-0.61
|
-0.50 | -0.53 | -0.52 | -0.09 |
| Diluted Earnings Per Share |
22.00%
-0.61
|
-0.50 | -0.53 | -0.52 | -0.09 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):